- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | QT IMAGING HOLDINGS, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 24.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 16.01. | QT Imaging files to sell 8.81M shares of common stock for holders | 1 | Seeking Alpha | ||
| 16.01. | QT IMAGING HOLDINGS, INC. - S-1, General form for registration of securities | - | SEC Filings | ||
| QT IMAGING Aktie jetzt für 0€ handeln | |||||
| 13.01. | QT Imaging sichert finanzielle Grundlage und prognostiziert Wachstum | 1 | Investing.com Deutsch | ||
| 10.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 20.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.12.24 | QT Imaging announces new commercial shipment in partnership with Couri Center | 1 | Seeking Alpha | ||
| 11.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.24 | QT Imaging Holdings GAAP EPS of -$0.17, revenue of $0.96M | 3 | Seeking Alpha | ||
| 13.11.24 | QT Imaging Announces Third Quarter 2024 Financial Results | 134 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen | |
| 13.11.24 | QT IMAGING HOLDINGS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 01.11.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.24 | QT Imaging ändert Vereinbarung zur Verlängerung der Laufzeit | 1 | Investing.com Deutsch | ||
| 30.09.24 | QT Imaging Amends Agreement to Extend Maturity Date | 1 | Investing.com | ||
| 30.09.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.09.24 | QT Imaging Holdings faces potential Nasdaq delisting | 1 | Investing.com | ||
| 10.09.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.08.24 | QT Imaging Holdings GAAP EPS of -$0.30, revenue of $1.7M | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 561,20 | +1,81 % | Intuitive Surgical: Roboter-Pionier nach Rally unter Druck - Grund zur Sorge? | Die neue Handelswoche schüttelt die Anleger kräftig durch, nachdem der neue KI-Chatbot aus China insbesondere die US-Tech-Titel massiv unter Druck gesetzt hat. Kurz vor dem Handelsstart an den US-Börsen... ► Artikel lesen | |
| SERNOVA | 0,129 | -8,44 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism | LONDON, Ontario and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,803 | -1,11 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,757 | 0,00 % | PA GOODDOCTOR (01833): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | ||
| MOUNTAIN VALLEY MD | 0,023 | +22,58 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,750 | +2,74 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 0,935 | -3,51 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
| VERU | 0,540 | +0,65 % | Veru Inc.: Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY (Semaglutide) for Weight Reduction | -- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on average... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,878 | -1,63 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VOLITIONRX | 0,586 | 0,00 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
| EKSO BIONICS | 0,510 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
| IMUNON | 0,835 | -2,91 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| BEYOND AIR | 0,368 | -1,08 % | Beyond Air files for $200M mixed securities shelf | ||
| AVINGER | 0,575 | 0,00 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,648 | +2,37 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights |
QT IMAGING HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,114 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QT IMAGING HOLDINGS INC finden Sie auf Wallstreet Online.
